Follow
Melissa M Wolf
Melissa M Wolf
Verified email at vanderbilt.edu
Title
Cited by
Cited by
Year
Cell-programmed nutrient partitioning in the tumour microenvironment
BI Reinfeld, MZ Madden, MM Wolf, A Chytil, JE Bader, AR Patterson, ...
Nature 593 (7858), 282-288, 2021
5932021
MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells via regulation of mitochondrial oxidative phosphorylation
K Lee, JM Giltnane, JM Balko, LJ Schwarz, AL Guerrero-Zotano, ...
Cell metabolism 26 (4), 633-647. e7, 2017
5162017
Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism
MO Johnson, MM Wolf, MZ Madden, G Andrejeva, A Sugiura, ...
Cell 175 (7), 1780-1795. e19, 2018
5152018
Modeling clear cell renal cell carcinoma and therapeutic implications
MM Wolf, W Kimryn Rathmell, KE Beckermann
Oncogene 39 (17), 3413-3426, 2020
1092020
MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function
A Sugiura, G Andrejeva, K Voss, DR Heintzman, X Xu, MZ Madden, X Ye, ...
Immunity 55 (1), 65-81. e9, 2022
882022
Targeting PIM kinase with PD1 inhibition improves immunotherapeutic antitumor T-cell response
S Chatterjee, P Chakraborty, A Daenthanasanmak, S Iamsawat, ...
Clinical cancer research 25 (3), 1036-1049, 2019
512019
Fine-needle aspiration-based patient-derived cancer organoids
AE Vilgelm, K Bergdorf, M Wolf, V Bharti, R Shattuck-Brandt, A Blevins, ...
Iscience 23 (8), 2020
392020
Mutant KRAS exosomes alter the metabolic state of recipient colonic epithelial cells
Q Zhang, DK Jeppesen, JN Higginbotham, MD Beckler, EJ Poulin, ...
Cellular and Molecular Gastroenterology and Hepatology 5 (4), 627-629. e6, 2018
382018
STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy
L Wang-Bishop, BR Kimmel, VM Ngwa, MZ Madden, JJ Baljon, ...
Science immunology 8 (83), eadd1153, 2023
192023
Differential effects of glutamine inhibition strategies on antitumor CD8 T cells
MZ Madden, X Ye, C Chi, EL Fisher, MM Wolf, GA Needle, JE Bader, ...
J. Immunol. 211, 563-575, 2023
72023
Immunogenicity in renal cell carcinoma: Shifting focus to alternative sources of tumour-specific antigens
MM Wolf, WK Rathmell, AA de Cubas
Nature Reviews Nephrology 19 (7), 440-450, 2023
62023
Metabolomics analysis reveals differential T cell serine metabolism as a target in autoimmunity
G Andrejeva, MM Wolf, MO Johnson
J. Immunol 200 (167.7), 2018
52018
PD-1 is induced on tumor-associated macrophages in obesity to directly restrain anti-tumor immunity
JE Bader, MM Wolf, MZ Madden, BI Reinfeld, EN Arner, ES Hathaway, ...
bioRxiv, 2022.11. 12.515348, 2022
22022
ACSS2 regulates HIF-2α degradation through the E3-ubiquitin ligase MUL1 in clear cell renal cell carcinoma
ZA Bacigalupa, WA Brown, ES Krystofiak, MM Wolf, RA Hongo, M Landis, ...
bioRxiv, 2022.04. 21.489116, 2022
22022
Nutrient partitioning in the tumor microenvironment and FDG-PET imaging
MZ Madden, BI Reinfeld, MM Wolf, AS Cohen, HC Manning, WK Rathmell, ...
The Journal of Immunology 204 (1_Supplement), 240.4-240.4, 2020
12020
VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesis
MM Wolf, MZ Madden, EN Arner, JE Bader, X Ye, L Vlach, ML Tigue, ...
Journal of Clinical Investigation 134 (8), e173934, 2024
2024
VHL Deficiency and the Tumor Microenvironment in Renal Cell Carcinoma
MM Wolf
2024
SETD2 loss promotes macrophage infiltration and metastasis in RCC
EN Arner, MM Wolf, L Vlach, JC Rathmell, WK Rathmell
Cancer Research 84 (6_Supplement), 1387-1387, 2024
2024
Tissue-Specific Dependence of Th1 Cells on the Amino Acid Transporter SLC38A1 in Inflammation
A Sugiura, KL Beier, C Chi, DR Heintzman, X Ye, MM Wolf, AR Patterson, ...
bioRxiv, 2023
2023
Deciphering molecular mechanisms of metastasis in renal cell carcinoma
EN Arner, MM Wolf, L Vlach, VJ Sih, DL Greenwood, S Haake, ...
Cancer Research 83 (7_Supplement), 1229-1229, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20